These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 26584874)

  • 21. Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling.
    Melki I; Rose Y; Uggenti C; Van Eyck L; Frémond ML; Kitabayashi N; Rice GI; Jenkinson EM; Boulai A; Jeremiah N; Gattorno M; Volpi S; Sacco O; Terheggen-Lagro SWJ; Tiddens HAWM; Meyts I; Morren MA; De Haes P; Wouters C; Legius E; Corveleyn A; Rieux-Laucat F; Bodemer C; Callebaut I; Rodero MP; Crow YJ
    J Allergy Clin Immunol; 2017 Aug; 140(2):543-552.e5. PubMed ID: 28087229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus.
    Kim H; Sanchez GA; Goldbach-Mansky R
    J Mol Med (Berl); 2016 Oct; 94(10):1111-1127. PubMed ID: 27678529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STING-Associated Vasculopathy with Onset in Infancy in Three Children with New Clinical Aspect and Unsatisfactory Therapeutic Responses to Tofacitinib.
    Tang X; Xu H; Zhou C; Peng Y; Liu H; Liu J; Li H; Yang H; Zhao S
    J Clin Immunol; 2020 Jan; 40(1):114-122. PubMed ID: 31705453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Livedo racemosa and digital necrosis in a patient with primary seronegative antiphospholipid syndrome and fibromuscular dysplasia of peripheral arteries.
    Eisendle K; Jaschke W; Sepp N
    Br J Dermatol; 2007 Aug; 157(2):389-92. PubMed ID: 17553034
    [No Abstract]   [Full Text] [Related]  

  • 25. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.
    de Jesus AA; Hou Y; Brooks S; Malle L; Biancotto A; Huang Y; Calvo KR; Marrero B; Moir S; Oler AJ; Deng Z; Montealegre Sanchez GA; Ahmed A; Allenspach E; Arabshahi B; Behrens E; Benseler S; Bezrodnik L; Bout-Tabaku S; Brescia AC; Brown D; Burnham JM; Caldirola MS; Carrasco R; Chan AY; Cimaz R; Dancey P; Dare J; DeGuzman M; Dimitriades V; Ferguson I; Ferguson P; Finn L; Gattorno M; Grom AA; Hanson EP; Hashkes PJ; Hedrich CM; Herzog R; Horneff G; Jerath R; Kessler E; Kim H; Kingsbury DJ; Laxer RM; Lee PY; Lee-Kirsch MA; Lewandowski L; Li S; Lilleby V; Mammadova V; Moorthy LN; Nasrullayeva G; O'Neil KM; Onel K; Ozen S; Pan N; Pillet P; Piotto DG; Punaro MG; Reiff A; Reinhardt A; Rider LG; Rivas-Chacon R; Ronis T; Rösen-Wolff A; Roth J; Ruth NM; Rygg M; Schmeling H; Schulert G; Scott C; Seminario G; Shulman A; Sivaraman V; Son MB; Stepanovskiy Y; Stringer E; Taber S; Terreri MT; Tifft C; Torgerson T; Tosi L; Van Royen-Kerkhof A; Wampler Muskardin T; Canna SW; Goldbach-Mansky R
    J Clin Invest; 2020 Apr; 130(4):1669-1682. PubMed ID: 31874111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hierarchy of clinical manifestations in SAVI N153S and V154M mouse models.
    Motwani M; Pawaria S; Bernier J; Moses S; Henry K; Fang T; Burkly L; Marshak-Rothstein A; Fitzgerald KA
    Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7941-7950. PubMed ID: 30944222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and Safety of Janus Kinase Inhibitors in Type I Interferon-Mediated Monogenic Autoinflammatory Disorders: A Scoping Review.
    Gómez-Arias PJ; Gómez-García F; Hernández-Parada J; Montilla-López AM; Ruano J; Parra-Peralbo E
    Dermatol Ther (Heidelb); 2021 Jun; 11(3):733-750. PubMed ID: 33856640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioresistant cells initiate lymphocyte-dependent lung inflammation and IFNγ-dependent mortality in STING gain-of-function mice.
    Gao KM; Motwani M; Tedder T; Marshak-Rothstein A; Fitzgerald KA
    Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2202327119. PubMed ID: 35696583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unraveling the diagnostic odyssey: stimulator of interferon gene-associated vasculopathy with onset in infancy in a 30-year-old female.
    Kim HR; Lim SH; Park JS; Suh DI; Lee S; Kim SY; Chae JH; Kim SH
    J Rheum Dis; 2024 Jul; 31(3):182-187. PubMed ID: 38957365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interstitial lung disease in autoinflammatory disease in childhood: A systematic review of the literature.
    Nayir Buyuksahin H; Basaran O; Balık Z; Bilginer Y; Ozen S; Dogru D
    Pediatr Pulmonol; 2023 Feb; 58(2):367-373. PubMed ID: 36314652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type I interferon-independent T cell impairment in a Tmem173 N153S/WT mouse model of STING associated vasculopathy with onset in infancy (SAVI).
    Siedel H; Roers A; Rösen-Wolff A; Luksch H
    Clin Immunol; 2020 Jul; 216():108466. PubMed ID: 32470544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Mutation Outside the Dimerization Domain Causing Atypical STING-Associated Vasculopathy With Onset in Infancy.
    Saldanha RG; Balka KR; Davidson S; Wainstein BK; Wong M; Macintosh R; Loo CKC; Weber MA; Kamath V; ; ; Moghaddas F; De Nardo D; Gray PE; Masters SL
    Front Immunol; 2018; 9():1535. PubMed ID: 30038614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe Pulmonary Fibrosis as the First Manifestation of Interferonopathy (TMEM173 Mutation).
    Picard C; Thouvenin G; Kannengiesser C; Dubus JC; Jeremiah N; Rieux-Laucat F; Crestani B; Belot A; Thivolet-Béjui F; Secq V; Ménard C; Reynaud-Gaubert M; Reix P
    Chest; 2016 Sep; 150(3):e65-71. PubMed ID: 27613991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Challenge of Diagnosing SAVI: Case Studies.
    Cao Y; Jiang LP
    Pediatr Allergy Immunol Pulmonol; 2019 Dec; 32(4):167-172. PubMed ID: 32140288
    [No Abstract]   [Full Text] [Related]  

  • 35. Baricitinib experience on STING-associated vasculopathy with onset in infancy: A representative case from Turkey.
    Balci S; Ekinci RMK; de Jesus AA; Goldbach-Mansky R; Yilmaz M
    Clin Immunol; 2020 Mar; 212():108273. PubMed ID: 31626957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lung Transplantation under a Janus Kinase Inhibitor in Three Patients with SAVI Syndrome.
    Berrada KR; Belot A; Neven B; Ohlmann C; Tronc F; Rice G; Thouvenin G; Dubus JC; Mazenq J; Frémond ML; Stremler N; Soummer-Feuillet S; Cottin V; Reix P
    J Clin Immunol; 2023 Nov; 43(8):2156-2164. PubMed ID: 37814086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [When to consider type I interferonopathy in adulthood?].
    David C; Frémond ML
    Rev Med Interne; 2022 Jun; 43(6):347-355. PubMed ID: 35177256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The IFN-γ receptor promotes immune dysregulation and disease in STING gain-of-function mice.
    Stinson WA; Miner CA; Zhao FR; Lundgren AJ; Poddar S; Miner JJ
    JCI Insight; 2022 Sep; 7(17):. PubMed ID: 36073546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Possible Werner syndrome. A unique association with spontaneous digital gangrene in infancy and decreased life span of cultured skin fibroblasts.
    Iijima S; Arinami T; Otsuka F
    Arch Dermatol; 1992 Sep; 128(9):1238-42. PubMed ID: 1519939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferonopathies: From concept to clinical practice.
    Mendonça LO; Frémond ML
    Best Pract Res Clin Rheumatol; 2024 Sep; 38(3):101975. PubMed ID: 39122631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.